FDA approves groundbreaking sickle cell anemia treatment

The FDA has approved a groundbreaking cure for sickle cell anemia called Casgevy which uses the gene-editing tool CRISPR. NBC News’ Rehema Ellis has more details on the new hope for those suffering with the debilitating blood disorder.

NBC News LogoIsrael-Hamas warPoliticsU.S. NewsWorldBusinessHealthNBC News TiplineVideoCulture & trends

My NewsManage ProfileEmail PreferencesSign OutSearchSearchProfile

 My NewsSign Out Sign InCreate your free profileSections




Post ID: c3ccda63-4111-4036-98e2-3abae456505d
Rating: 5
Created: 4 months ago
Your ad can be here
Create Post

Similar classified ads

News's other ads